| 1 |
[GO] |
2024―Feb―12 |
Safety and immunogenicity of an adjuvanted recombinant spike protein-based severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine, SpikeVet™, in selected Carnivora, Primates and Artiodactyla in Australian zoos |
David J. McLelland, Michael Lynch, Larry Vogelnest, Paul Eden, Alisa Wallace, Jayne Weller, et al. (+5) Sam Young, Rebecca Vaughan-Higgins, Anna Antipov, Yoshikazu Honda-Okubo, Nikolai Petrovsky |